| Literature DB >> 16212807 |
Susan M Chang1, Sharon L Reynolds, Nicholas Butowski, Kathleen R Lamborn, Jan C Buckner, Richard S Kaplan, Darell D Bigner.
Abstract
We present guidelines to standardize the reporting of phase 1 and phase 2 neuro-oncology trials. The guidelines are also intended to assist with accurate interpretation of results from these trials, to facilitate the peer-review process, and to expedite the publication of important and accurate manuscripts. Our guidelines are summarized in a checklist format that can be used as a framework from which to construct a phase 1 or 2 clinical trial.Mesh:
Year: 2005 PMID: 16212807 PMCID: PMC1871726 DOI: 10.1215/S1152851705000554
Source DB: PubMed Journal: Neuro Oncol ISSN: 1522-8517 Impact factor: 12.300